Development and feasibility of a telemonitoring tool with full integration in the electronic medical record: a proof of concept study for patients with inflammatory bowel disease in remission on biological therapy

References

• Cosnes J, Gower–Rousseau C, Seksik P, et al. Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology. 2011;140(6):1785–1794.
   PubMed Web of Science ®Google Scholar
• Burisch J, Munkholm P. The epidemiology of inflammatory bowel disease. Scand J Gastroenterol. 2015;50(8):942–951.
   PubMed Web of Science ®Google Scholar
• Zand A, van Welmoed K, Inserra K, et al. Presenteeism in inflammatory bowel diseases: a hidden problem with significant economic impact. Inflamm Bowel Dis. 2015;21(7):1623–1630.
   PubMed Web of Science ®Google Scholar
• Sewitch MJ, Abrahamowicz M, Bitton A, et al. Psychological distress, social support, and disease activity in patients with inflammatory bowel disease. Am J Gastroenterology. 2001;96(5):1470–1479.
   PubMed Web of Science ®Google Scholar
• Van Der Valk ME, Mangen M, Leenders M, on behalf of the COIN study group and the Dutch Initiative on Crohn and Colitis, et al. Healthcare costs of inflammatory bowel disease have shifted from hospitalisation and surgery towards anti-TNFα therapy: results from the COIN study. Gut. 2014;63(1):72–79.
   PubMed Web of Science ®Google Scholar
• Colombel J-F, Narula N, Peyrin-Biroulet L. Management strategies to improve outcomes of patients with inflammatory bowel diseases. Gastroenterology. 2017;152(2):351–361.
   PubMed Web of Science ®Google Scholar
• Sandborn WJ, Hanauer S, Van Assche G, et al. Treating beyond symptoms with a view to improving patient outcomes in inflammatory bowel diseases. J Crohns Colitis. 2014;8(9):927–935.
   PubMed Web of Science ®Google Scholar
• Calvet X, Panés J, Alfaro N, et al. Delphi consensus statement: quality indicators for inflammatory bowel disease comprehensive care units. J Crohns Colitis. 2014;8(3):240–251.
   PubMed Web of Science ®Google Scholar
• Mawdsley J, Irving PM, Makins RJ, et al. Optimizing quality of outpatient care for patients with inflammatory bowel disease: the importance of specialist clinics. Eur J Gastroenterol Hepatol. 2006;18(3):249–253.
   PubMed Web of Science ®Google Scholar
• Lofland JH, Johnson PT, Ingham MP, et al. Shared decision-making for biologic treatment of autoimmune disease: influence on adherence, persistence, satisfaction, and health care costs. Patient Prefer Adherence . 2017;11:947–958.
   PubMed Web of Science ®Google Scholar
• Veilleux S, Noiseux I, Lachapelle N, et al. Patients’ perception of their involvement in shared treatment decision making: key factors in the treatment of inflammatory bowel disease. Patient Educ Couns. 2018;101(2):331–339.
   PubMed Web of Science ®Google Scholar
• Peyrin-Biroulet L, Van Assche G, Armuzzi A, et al. Implementing the concept of continuous clinical response into clinical practice for ulcerative colitis. Clin Gastroenterol Hepatol. 2017;15(8):1154–1161.
   PubMed Web of Science ®Google Scholar
• Cross RK, Arora M, Finkelstein J. Acceptance of telemanagement is high in patients with inflammatory bowel disease. J Clin Gastroenterol. 2006;40(3):200–208.
   PubMed Web of Science ®Google Scholar
• de Jong MJ, van der Meulen-de Jong AE, Romberg-Camps MJ, et al. Telemedicine for management of inflammatory bowel disease (myIBDcoach): a pragmatic, multicentre, randomised controlled trial. Lancet. 2017;390(10098):959–968.
   PubMed Web of Science ®Google Scholar
• Del Hoyo J, Nos P, Faubel R, et al. A web-based telemanagement system for improving disease activity and quality of life in patients with complex inflammatory bowel disease: pilot randomized controlled trial. J Med Internet Res. 2018;20(11):e11602.
   PubMed Web of Science ®Google Scholar
• Cross RK, Jambaulikar G, Langenberg P, et al. TELEmedicine for Patients with Inflammatory Bowel Disease (TELE-IBD): design and implementation of randomized clinical trial. Contemp Clin Trials. 2015;42:132–144.
   PubMed Web of Science ®Google Scholar
• www.nexuzhealth.be.
   Google Scholar
• Khanna R, Zou G, D'Haens G, et al. A retrospective analysis: the development of patient reported outcome measures for the assessment of Crohn’s disease activity. Aliment Pharmacol Ther. 2015;41(1):77–86.
   PubMed Web of Science ®Google Scholar
• Jairath V, Khanna R, Zou GY, et al. Development of interim patient-reported outcome measures for the assessment of ulcerative colitis disease activity in clinical trials. Aliment Pharmacol Ther. 2015;42(10):1200–1210.
   PubMed Web of Science ®Google Scholar
• McDermott E, Keegan D, Byrne K, et al. The Short Health Scale: a valid and reliable measure of health related quality of life in English speaking inflammatory bowel disease patients. J Crohns Colitis. 2013;7(8):616–621.
   PubMed Web of Science ®Google Scholar
• Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics. 1993;4(5):353–365.
   PubMed Web of Science ®Google Scholar
• Reilly MC, Tanner A, Meltzer EO. Work, classroom and activity impairment instruments. Clin Drug Investig. 1996;11(5):278–288.
   Web of Science ®Google Scholar
• Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med. 1987;317(26):1625–1629.
   PubMed Web of Science ®Google Scholar
• Rutgeerts P, Sandborn WJ, Feagan BG, et al. Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med. 2005;353(23):2462–2476.
   PubMed Web of Science ®Google Scholar
• Harvey RF, Bradshaw JM. A simple index of Crohn's-disease activity. Lancet. 1980;1(8167):514.
   PubMed Web of Science ®Google Scholar
• Sack C, Phan VA, Grafton R, et al. A chronic care model significantly decreases costs and healthcare utilisation in patients with inflammatory bowel disease. J Crohns Colitis. 2012;6(3):302–310.
   PubMed Web of Science ®Google Scholar
• Walsh A, Travis S. What’s app? Electronic health technology in inflammatory bowel disease. Intest Res. 2018;16(3):366–373.
   PubMed Web of Science ®Google Scholar
• Jackson BD, Gray K, Knowles SR, et al. EHealth technologies in inflammatory bowel disease: a systematic review. ECCOJC. 2016;10(9):1103–1121.
   Web of Science ®Google Scholar
• Greenhalgh T, Wherton J, Papoutsi C, et al. Beyond adoption: a new framework for theorizing and evaluating nonadoption, abandonment, and challenges to the scale-up, spread, and sustainability of health and care technologies. J Med Internet Res. 2017;19(11):e367.
   PubMed Web of Science ®Google Scholar
• Pedersen N, Thielsen P, Martinsen L, et al. eHealth. Inflammatory Bowel Diseases. 2014;20(12):2276–2285. doi:10.1097/MIB.0000000000000199.
   PubMed Web of Science ®Google Scholar
• Sebastian S, Roberts J, Waller J, et al. Remote Monitoring of Patient-Reported Outcomes in Ulcerative Colitis: A Prospective Real-World Pilot Study. PharmacoEconomics Open. 2019;3(3):359–365. doi:10.1007/s41669-019-0121-8.
   PubMed Web of Science ®Google Scholar